Skip to main content

Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy

Deliverables

International Network Symposium

International Network Symposium held

Summer School

Summer School held

Feature article on Peptide-Drug Conjugates

Feature article on Peptide-Drug Conjugates published in a popular scientific journal

Special issue on Peptide-Drug Conjugates

Special issue on Peptide-Drug Conjugates published in a scientific journal

Completion of Website

Completion of Website

Videos

Videos on ETN activities published by Beilstein TV

Searching for OpenAIRE data...

Publications

Tumor Targeting with an iso DGR-Drug Conjugate


Published in: ISSN 0947-6539
DOI: 10.1002/chem.201701844

Convenient Preparation of 18F-Labeled Peptide Probes for Potential Claudin-4 PET Imaging

Author(s): Lucia Feni, M. Omrane, Moritz Fischer, Boris Zlatopolskiy, Bernd Neumaier, Ines Neundorf
Published in: Pharmaceuticals, Issue 10/4, 2017, Page(s) 99, ISSN 1424-8247
DOI: 10.3390/ph10040099

Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery

Author(s): Sabine Schuster, Beáta Biri-Kovács, Bálint Szeder, Viktor Farkas, László Buday, Zsuzsanna Szabó, Gábor Halmos, Gábor Mező
Published in: Beilstein Journal of Organic Chemistry, Issue 14, 2018, Page(s) 756-771, ISSN 1860-5397
DOI: 10.3762/bjoc.14.64

Development of novel cyclic NGR peptide–daunomycin conjugates with dual targeting property

Author(s): Andrea Angelo Pierluigi Tripodi, Szilárd Tóth, Kata Nóra Enyedi, Gitta Schlosser, Gergely Szakács, Gábor Mező
Published in: Beilstein Journal of Organic Chemistry, Issue 14, 2018, Page(s) 911-918, ISSN 1860-5397
DOI: 10.3762/bjoc.14.78

Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-α-amanitin conjugates for tumor-targeting

Author(s): Lizeth Bodero, Paula López Rivas, Barbara Korsak, Torsten Hechler, Andreas Pahl, Christoph Müller, Daniela Arosio, Luca Pignataro, Cesare Gennari, Umberto Piarulli
Published in: Beilstein Journal of Organic Chemistry, Issue 14, 2018, Page(s) 407-415, ISSN 1860-5397
DOI: 10.3762/bjoc.14.29

Novel unit B cryptophycin analogues as payloads for targeted therapy

Author(s): Eduard Figueras, Adina Borbély, Mohamed Ismail, Marcel Frese, Norbert Sewald
Published in: Beilstein Journal of Organic Chemistry, Issue 14, 2018, Page(s) 1281-1286, ISSN 1860-5397
DOI: 10.3762/bjoc.14.109

Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification

Author(s): Sabine Schuster, Beáta Biri-Kovács, Bálint Szeder, László Buday, János Gardi, Zsuzsanna Szabó, Gábor Halmos, Gábor Mező
Published in: Pharmaceutics, Issue 10/4, 2018, Page(s) 223, ISSN 1999-4923
DOI: 10.3390/pharmaceutics10040223

In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas

Author(s): Samuele Cazzamalli, Eduard Figueras, Lilla Pethő, Adina Borbély, Christian Steinkühler, Dario Neri, Norbert Sewald
Published in: ACS Omega, Issue 3/11, 2018, Page(s) 14726-14731, ISSN 2470-1343
DOI: 10.1021/acsomega.8b02350

Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting


Published in: ISSN 1075-2617
DOI: 10.1002/psc.3015

Characterization of a Cell-Penetrating Peptide with Potential Anticancer Activity


Published in: ISSN 1860-7187
DOI: 10.1002/cmdc.201600498

The Current Role of Cell-Penetrating Peptides in Cancer Therapy.

Author(s): Lucia Feni, Ines Neundorf
Published in: Peptides and Peptide-based Biomaterials and their Biomedical Applications. Advances in Experimental Medicine and Biology., Issue Vol 1030, 2017, Page(s) 279-295
DOI: 10.1007/978-3-319-66095-0_13